NCT06109779 2026-03-04
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
AstraZeneca
Phase 3 Active not recruiting
AstraZeneca
Genfleet Therapeutics (Shanghai) Inc.
Sunshine Lake Pharma Co., Ltd.
Sanofi
Taiho Pharmaceutical Co., Ltd.